22 Jan 2018 Juno's stock price, already high following rumors of the impending deal and Juno Therapeutics, Inc. (NASDAQ:JUNO) today announced the 22 Jan 2018 As one might expect, Juno's share price spiked more than 26 percent today to just under $86 a share. Celgene's stock price, however, barely 22 Jan 2018 SUMMIT, N.J. & SEATTLE–(BUSINESS WIRE)– Celgene Corporation (NASDAQ: CELG) and Juno Therapeutics, Inc. (NASDAQ:JUNO) today Riding High, Biotech Firms Remain Wary. Soaring stock prices and major advances in fighting diseases have some saying the industry has turned a corner and 22 Jan 2018 on Monday said it agreed to buy Juno Therapeutics Inc. for $87 a share in cash, or about $9 billion, in a move that will expand Celgene's portfolio 24 Jan 2020 While $752 million is a princely sum, it only covers the amount Juno might have 10 stocks we like better than Bristol-Myers Squibb SBI plunged more than 7 percent after cutting interest rates on savings bank accounts. Where Circuit Breakers Kick In Today 3 days ago · These 14 Stocks Are Stupid jobs with Juno Therapeutics to view and apply for now with BioSpace. Allogene Therapeutics began trading on the Nasdaq Stock Exchange today under the ALLO ticker. The price was at the top of its range, $18 per share. The company
24 Jan 2020 While $752 million is a princely sum, it only covers the amount Juno might have 10 stocks we like better than Bristol-Myers Squibb SBI plunged more than 7 percent after cutting interest rates on savings bank accounts. Where Circuit Breakers Kick In Today 3 days ago · These 14 Stocks Are Stupid jobs with Juno Therapeutics to view and apply for now with BioSpace. Allogene Therapeutics began trading on the Nasdaq Stock Exchange today under the ALLO ticker. The price was at the top of its range, $18 per share. The company
Juno Therapeutics (JUNO) Stock: Climbing On Potential ... Jan 17, 2018 · Juno Therapeutics Inc (NASDAQ: JUNO) is having an overwhelmingly strong start to the trading session this morning after news broke that the company could …
Why Juno Therapeutics Stock Is Soaring Today | Nasdaq
Sep 21, 2017 · SEATTLE, Sep 21, 2017 (BUSINESS WIRE) -- Juno Therapeutics, Inc. JUNO, a biopharmaceutical company developing innovative cellular immunotherapies for the treatment of cancer, today announced the